There are three main types of breast cancer, as determined by the types of receptors they possess: 70% of all breast cancer are hormone-receptor-positive, with either oestrogen (ER) or progesterone (PR) receptors; 15–20% are ERBB2 (HER2)-positive; and 15% have none of these receptors and are termed triple negative [4]. This evidence concerns the gene ERBB2 and breast carcinoma.